companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

SPRATT FINANCIAL SERVICES INC

RICHMOND HILL-Canada

Company Name:
Corporate Name:
SPRATT FINANCIAL SERVICES INC
Company Title:  
Company Description:  
Keywords to Search:  
Company Address: 165 East Beaver Creek Rd,RICHMOND HILL,ON,Canada 
ZIP Code:
Postal Code:
L4B 
Telephone Number: 9058822015 
Fax Number:  
Website:
 
Email:
 
USA SIC Code(Standard Industrial Classification Code):
91380 
USA SIC Description:
FINANCIAL PLANNING CONSULTANTS & SERVICES 
Number of Employees:
 
Sales Amount:
$500,000 to $1 million 
Credit History:
Credit Report:
Good 
Contact Person:
 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
SPRING MAPLE SPA
SPRING CAPITAL MANAGEMENT
SPRING CAPITAL MANAGEMENT GROU
Next company profile:
SPRACKMAN C S INSURANCE AGENCY LTD
SPOTLITE CASUAL WEAR
SPORTS MEDICINE SPECIALISTS










Company News:
  • Diabetes treatment algorithms Iv Insulin Infusion Protocol . . .
    IV insulins include Regular, aspart and glul our D5W or D5W1⁄2NS at 100–200 mL hour r equivalent (TPN, enteral feeding, etc ) Adjusting the Infusion: Algorithm 1: Start here for most patients Algorithm 2: For patients not controlled with Algorithm 1, or start here if s p CABG, solid organ or islet cell transpla
  • Intravenous Insulin Management: Adult ICU - UI Health Care
    Resume hourly glucose monitoring with any of the following: change in insulin infusion rate, significant change in clinical status, initiation or cessation of pressor therapy, initiation or cessation of renal therapy (i e , hemodialysis, CVVH), change in nutritional support, or glucocorticoid supplementation
  • Curriculum Vitae: Daniel Spratt
    Daniel E Spratt, PI 07 2014-06 2019 $410,156 ($136,718) Phase 1 Trial of [18F] Dihydro-testosterone PET and MR imaging in patients with localized prostate cancer
  • Presentation - COMPPARE
    Daniel E Spratt, MD Associate Professor Snow Professor and Vice Chair of Research, Department of Radiation Oncology Chair, Genitourinary Division of Clinical Research, Rogel Cancer Center
  • James D. Spratt, Jr. - Southeast Fellows Institute
    James D Spratt, Jr te administration in Atlanta, Georgia He has over forty years of experience in trusts and estates matters, related tax issues, and tax and probate contro ersies relating to trusts and estates His practice focuses on wealth transfer planning, busi
  • Donald E. Spratt, Ph. D. - Clark University
    Instructed undergraduate (junior and senior) and graduate Biochemistry Molecular Biology (BCMB), Biology (BIOL), and Chemistry (CHEM) majors in lecture and laboratory settings
  • Optimizing Hospital Use of Intravenous Insulin Therapy . . .
    Objective: To assess the efficacy and safety of intra-venous (IV) insulin administration with use of our institu-tion’s old protocol (pre-nomogram phase) as compared with our new insulin nomogram (post-nomogram phase), which titrates insulin dose based on the rate of change of plasma glucose values and uses multipliers to determine the new insul




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer